title: Bone scan as a stratification variable in advanced prostate cancer.
abstract: The serial technetium 99 (99Tc) bone scans of 76 patients with Stage D-2 prostate cancers were reviewed. Sites of metastases in skeletal areas in decreasing order were vertebrae, ribs, pelvis, long bones, and skull. Patients with one or two involved skeletal areas had a significantly longer progression-free interval and survival time than patients with three or more bony areas of uptake. Bone scans might be used as a stratification variable in future prospective clinical trials of Stage D-2 prostate cancer.
authors.affiliation: Division of Urology, University of Illinois Hospital, Chicago.
authors.forename: G
authors.initials: G
authors.lastname: Knudson
authors.forename: G
authors.initials: G
authors.lastname: Grinis
authors.forename: V
authors.initials: V
authors.lastname: Lopez-Majano
authors.forename: P
authors.initials: P
authors.lastname: Sansi
authors.forename: P
authors.initials: P
authors.lastname: Targonski
authors.forename: M
authors.initials: M
authors.lastname: Rubenstein
authors.forename: R
authors.initials: R
authors.lastname: Sharifi
authors.forename: P
authors.initials: P
authors.lastname: Guinan
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D011877:Radionuclide Imaging; D015996:Survival Rate; D013669:Technetium Tc 99m Medronate
chemical_list: D013669:Technetium Tc 99m Medronate